Costa José Ricardo Sousa, Torriani Marcos Antonio, Hosni Elaini Sickert, D'Avila Otávio Pereira, de Figueiredo Paulo Jeovane
Department of Surgery, Traumatology, and Prosthesis Buco-Maxillo-Facial, Federal University of Pelotas Dental School, Pelotas, RS, Brazil.
J Oral Maxillofac Surg. 2011 Jun;69(6):e88-92. doi: 10.1016/j.joms.2010.06.204. Epub 2011 Jan 26.
The aim of the present study was to relate the use of 5% monoethanolamine oleate in sclerotherapy for vascular malformations and to suggest a protocol for its use.
A total of 53 patients with 66 vascular malformation lesions were treated with an intralesional injection of 5% monoethanolamine oleate at 0.1 mL/cm of lesion with at least a 15-day interval and as many as 4 applications. A descriptive statistical analysis was performed using SigmaPlot, version 9.0, software.
The treatment with the protocol suggested was effective in 65 cases, and in 1 case, surgical intervention was required.
Sclerotherapy was effective in the treatment of vascular malformations, and the method chosen was adequate for lesion resolution without complications.
本研究旨在探讨5%油酸单乙醇胺在血管畸形硬化治疗中的应用，并提出其使用方案。
共有53例患者的66处血管畸形病变接受了病灶内注射5%油酸单乙醇胺治疗，注射剂量为每厘米病灶0.1 mL，间隔至少15天，最多注射4次。使用SigmaPlot 9.0软件进行描述性统计分析。
采用建议方案治疗的65例有效，1例需要手术干预。
硬化治疗对血管畸形有效，所选方法足以解决病灶问题且无并发症。
